HomelandDefenseStocks.com Reports on The Security Implications of AIDS
POINT ROBERTS, Wash., July 16, 2004 - www.HomelandDefenseStocks.com, (HDS) an investor news portal for the Homeland Defense and Security Sector features the exclusive article “The Security Implications of AIDS”.

As the U.S. House of Representatives just passed Project BioShield, a 10-year, $6 billion budget to develop modern, effective drugs and vaccines to protect America against biological, chemical, nuclear and radiological weapon attacks, the implications of AIDS in the ‘War on Terror’ is examined.
 
HDS does not make recommendations, but offers a unique, free information portal to investors to research news, articles, interviews and a growing list of participating public companies. 

HDS Featured Company:

Aethlon Medical, Inc. (OTCBB: AEMD) is pioneering the development of viral filtration devices that rapidly reduce the presence of infectious disease and toxins in the body. Aethlon has published compelling human blood studies of the Hemopurifier(TM) to treat HIV/AIDS and Hepatitis-C (HCV), and most recently, has announced that it is developing pathogen filtration devices to treat infectious agents used in biological warfare and terrorism. The Hemopurifier is a proprietary platform technology that converges the established scientific principles of affinity chromatography and hemodialysis as a means to augment the immune response of clearing viruses and toxins from the blood before cell and organ infection can occur.
 

The Security Implications of AIDS

By Allen R. Gibson

Excerpt:

In the 1990’s, AIDS was widely acknowledged to be the preeminent threat to health and security on the planet Particularly in the world’s underdeveloped countries, and most particularly in Africa, where an entire generation is threatened by the rampant spread of the disease.

Then 9-11 happened. Suddenly, the “War on Terror” took all the headlines, and most of the money and resources the US was prepared to commit to making the world a safer place.

What got obscured in the first three years of the War on Terror is that AIDS is a much greater source of terror, for far more people, than any religious fundamentalism, and America ignores this truth at her own peril.

 …While the debate continues, new drug resistant strains of the AIDS virus continue to evolve, and the hope of a vaccine against HIV has greatly diminished. Companies like Aethlon Medical, who is developing a viral filtration device designed to clear all strains of  HIV from infected blood, must navigate the geopolitical issues related to AIDS in addition to creating potentially relevant treatments. Ironically, the use of Aethlon's technology to treat HIV/AIDS and Hepatitis-C, has recently been expanded to defend against bioterror agents. It's just one example of how, in many ways, the ‘War on Terror’ and the ‘War on AIDS’ are the same war.

Full article click here: http://www.homelanddefensestocks.com/Companies/HomelandDefense/Articles/AIDS.asp

HomelandDefenseStock.com includes a growing list of public companies in the sector. Click here for a partial list of companies involved in homeland defense and security technology and solutions in Airport Security, Biodefense, Biometrics, Defense, Internet Security, Integrated Security, Military, Border and Port Security. www.InvestorIdeas.com/Companies/HomelandDefense/Articles/StockList.asp

Disclaimer: ECON Corporate Services is the owner of the domain www.HomelandDefenseStocks.com.   

The site does not make recommendations but does offer an information portal to investors to research news, articles and current research. The site is supported by its "featured companies" including: Aethlon Medical, Inc., MDM Group, Inc., Markland Technologies, Inc., Roaming Messenger, Inc. but the current list of stocks is provided as a free research tool to investors.

Disclaimer: www.InvestorIdeas.com/About/Disclaimer.asp     

Compensation Disclosure Specifics: www.InvestorIdeas.com/About/News/Clientspecifics.asp

Aethlon Medical, mentioned in this article, compensates Investorideas.com and its HDS portal $3000 per month plus restricted shares equivalent to $5000 per month

HomelandDefenseStocks.com is a Registered WA Trade Name

For more information contact:

Dawn Van Zant / Trevor Ruehs 

Toll free:         800-665-0411

Email: dvanzant@homelanddefensestocks.com or truehs@homelanddefensestocks.com

To subscribe or unsubscribe to this newsletter please hit reply to this email or email: cbillinkoff@investorideas.com and type in: SUBSCRIBE (HDS) or REMOVE (HDS) in the subject line.